Direct-To-Consumer Genotype Tests
You may have seen commercials for companies that provide DNA tests and health reports to the general public, often piggybacking on the public’s interest in genealogy and ancestry. We appreciate that their marketing efforts have brought the concept of genomics and health into the public eye, however the tests and reports that they deliver to the public are not medically comprehensive. These tests only show variants relayed through selected, single SNPs, which don’t tell the whole story from a clinical perspective.
Commercial Exome Tests
Some companies conduct whole genomic or exome sequencing – meaning they sequence all of your genes. Exome sequencing is a good choice if you are looking for a rare genetic illness, and you need to identify very large deletions or insertions. Examples of genetic illnesses include Huntington’s disease or genetic forms of breast cancer (i.e. BRCA). However, current exome reports do not tend to highlight gene interactions, role of variants, or potential modulation strategies. They are also cost prohibitive for routine use.
IntellxxDNA™ Clinical Tests & Analytic Reports
Created by clinicians for clinicians, IntellxxDNA™ is a clinical decision support tool that provides genomic data and analytics based on gene-to-gene and gene-to-environment interactions through SNP technology.
Whereas most commercial tests focus on just a few alleles or single SNPs, our technology and proprietary methodology dives into the interplay within multiple SNPs, as well as the role that minor alleles play in gene function. IntellxxDNA™’s reporting provides analytics on SNP variables and pairs these findings with odds ratios, a critical factor in clinical decision-making.
IntellxxDNA™’s data and analytics look at the complex intricacies of a patient’s genomic profile and how small variations within their DNA affect their quality of life and health risks. We include evidence-based, well-researched potential intervention strategies – encompassing environment, lifestyle, nutrition, supplements and medications. These components make our reports accessible and actionable for ease-of-use in clinical decision-making.